Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
$207K Hold
5,970
0.03% 221
2024
Q1
$224K Hold
5,970
0.03% 235
2023
Q4
$214K Sell
5,970
-59
-1% -$2.27K 0.03% 231
2023
Q3
$228K Hold
6,029
0.04% 214
2023
Q2
$246K Buy
6,029
+59
+1% +$2.44K 0.04% 216
2023
Q1
$250K Hold
5,970
0.04% 208
2022
Q4
$258K Hold
5,970
0.05% 202
2022
Q3
$224K Hold
5,970
0.04% 204
2022
Q2
$271K Hold
5,970
0.05% 198
2022
Q1
$284K Sell
5,970
-2,400
-29% -$102K 0.04% 210
2021
Q4
$345K Buy
8,370
+937
+13% +$35.3K 0.05% 201
2021
Q3
$256K Hold
7,433
0.04% 218
2021
Q2
$235K Buy
+7,433
New +$239K 0.04% 222

Other funds holding EXC

Abbrea Capital's EXC Position: Q2 2024 in Review

Abbrea Capital held its Exelon (EXC) position steady in Q2 2024 at 5,970 shares worth $207K. The position accounts for 0.03% of the portfolio, ranked #221.

Abbrea Capital first reported a position in EXC in Q2 2021 and has held it in 13 quarters since. The position peaked at $345K in Q4 2021. 991 funds tracked by Wall St. Rank hold EXC as of Q2 2024.

  • Abbrea Capital held 5,970 shares of Exelon worth $207K as of Q2 2024.
  • Abbrea Capital left its Exelon share count unchanged in Q2 2024.
  • Exelon made up 0.03% of Abbrea Capital's portfolio in Q2 2024, its #221 holding.
  • Abbrea Capital first reported a position in Exelon in Q2 2021 and has held it in 13 quarters since.
  • Abbrea Capital's Exelon position peaked at $345K in Q4 2021.
  • 991 funds tracked by Wall St. Rank held Exelon as of Q2 2024.

Based on Abbrea Capital's 13F filing for Q2 2024, filed 8 Aug 2024.